Keywords: dosing, begins, ph, ib, trial, genaera, trodusquemine

Dosing begins in Ph Ib trial of Genaera's trodusquemine

Article | 08 December 2008

Print This

US drug developer Genaera has started dosing subjects in study MSI-1436C-102, a multiple ascending-dose Phase Ib trial of trodusquemine ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in